Priority of PET-CT vs CT Thorax for EBUS-TBNA 22G vs 19G: Mesothorax Lymphadenopathy
Zarogoulidis P, Huang H, Hu Z, Wu N, Wang J, Petridis D, Tsakiridis K, Matthaios D, Kosmidis C, Hohenforst-Schmidt W, Tolis C, Boukovinas I, Courcoutsakis N, Nikolaidis G, Sardeli C, Bai C, Karapantzou C (2021)
Publication Type: Journal article
Publication year: 2021
Journal
Book Volume: 12
Pages Range: 5874-5878
Journal Issue: 19
DOI: 10.7150/jca.59892
Abstract
Introduction: Lung lesions and undiagnosed mesothorax lymphadenopathy is an issue that several doctors face in the everyday clinical practice. PET-CT and CT of the thorax are usually the first examinations to identify characteristics of the lesions before biopsy.
Patients and Methods: We performed a retrospective study with 450 patients that had EBUS-TBNA with 22G, Upgraded 22G and 19G needles with and without PET-CT in order to identify the cost effeteness of performing EBUS-TBNA before or after PET-CT. All centers used the same PET-CT equipment and EBUS-TBNA system. Three types of needle were used for the endoscopy in order to identify similarities and differences for the cost-effectiveness. The costs in every center for every examination and materials were the same.
Results: There were more block slices for 19G>22Gupgraded>21G>22G and there was cost-effectiveness when in general PET-CT was performed prior to biopsy of any lesion. 19G needle was more effective for lymphomas, while 22Gupgraded and 21G needles were more cost-effective when used for smaller lesions for primary lung cancer of metastatic disease.
Conclusions: We have been using PET-CT and EBUS-TBNA in the everyday clinical practice according to the current guidelines for initial disease staging and re-staging. However; we can also use both in a cost effective method based on the initial radiologic findings.
Involved external institutions
Democritus University of Thrace (DUTH) / Δημοκρίτειο Πανεπιστήμιο Θράκης
Greece (GR)
Euromedica Geniki Kliniki of Thessaloniki
Greece (GR)
Aristotle University of Thessaloniki
Greece (GR)
Second Military Medical University (SMMU) / 第二军医大学
China (CN)
Bioclinic Thessaloniki / Βιοκλινική Θεσσαλονίκης
Greece (GR)
Ludwig-Maximilians-Universität (LMU)
Germany (DE)
AHEPA University General Hospital / Πανεπιστημιακό Νοσοκομείο ΑΧΕΠΑ
Greece (GR)
General Hospital of Rhodes / Hospital Geniko Nosokomio Rodou "Andreas Papandreou" / Γενικό Νοσοκομείο Ρόδου
Greece (GR)
Alexander Technological Educational Institute of Thessaloniki (ATEITH)
Greece (GR)
Interbalkan Medical Center
Greece (GR)
Sana Kliniken AG
Germany (DE)
Greece (GR)
Euromedica Geniki Kliniki of Thessaloniki
Greece (GR)
Aristotle University of Thessaloniki
Greece (GR)
Second Military Medical University (SMMU) / 第二军医大学
China (CN)
Bioclinic Thessaloniki / Βιοκλινική Θεσσαλονίκης
Greece (GR)
Ludwig-Maximilians-Universität (LMU)
Germany (DE)
AHEPA University General Hospital / Πανεπιστημιακό Νοσοκομείο ΑΧΕΠΑ
Greece (GR)
General Hospital of Rhodes / Hospital Geniko Nosokomio Rodou "Andreas Papandreou" / Γενικό Νοσοκομείο Ρόδου
Greece (GR)
Alexander Technological Educational Institute of Thessaloniki (ATEITH)
Greece (GR)
Interbalkan Medical Center
Greece (GR)
Sana Kliniken AG
Germany (DE)
How to cite
APA:
Zarogoulidis, P., Huang, H., Hu, Z., Wu, N., Wang, J., Petridis, D.,... Karapantzou, C. (2021). Priority of PET-CT vs CT Thorax for EBUS-TBNA 22G vs 19G: Mesothorax Lymphadenopathy. Journal of Cancer, 12(19), 5874-5878. https://doi.org/10.7150/jca.59892
MLA:
Zarogoulidis, Paul, et al. "Priority of PET-CT vs CT Thorax for EBUS-TBNA 22G vs 19G: Mesothorax Lymphadenopathy." Journal of Cancer 12.19 (2021): 5874-5878.
BibTeX: Download